908 DEVICES INC. Revenue
908 DEVICES INC. (MASS) reported Revenue of $16.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-11
- 908 DEVICES INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $16.07M, a 23.31% increase year-over-year.
- 908 DEVICES INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $13.38M, a 13.62% increase year-over-year.
- 908 DEVICES INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $17.38M, a 21.17% increase year-over-year.
- 908 DEVICES INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $14.01M, a 3.54% decline year-over-year.
- 908 DEVICES INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $56.20M, a 17.70% increase from fiscal 2024.
- 908 DEVICES INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $47.75M, a 4.94% decline from fiscal 2023.
- 908 DEVICES INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $50.23M, a 7.21% increase from fiscal 2022.
- 908 DEVICES INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $46.85M, a 11.01% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $16.07M 10-Q · filed 2026-08-11 | $29.46M 10-Q · filed 2026-08-11 | $46.84M derived: sum of 3 quarters · filed 2026-08-11 | $60.84M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $13.38M 10-Q · filed 2026-05-06 | $30.76M derived: sum of 2 quarters · filed 2026-05-06 | $44.77M derived: sum of 3 quarters · filed 2026-05-06 | $57.80M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $17.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $31.39M derived: sum of 2 quarters · filed 2026-03-09 | $44.42M derived: sum of 3 quarters · filed 2026-08-11 | $56.20M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $14.01M 10-Q · filed 2025-11-10 | $27.04M derived: sum of 2 quarters · filed 2026-08-11 | $38.82M 10-Q · filed 2025-11-10 | $53.16M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $13.04M 10-Q · filed 2026-08-11 | $24.81M 10-Q · filed 2026-08-11 | $39.16M derived: sum of 3 quarters · filed 2026-08-11 | $53.67M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $11.78M 10-Q · filed 2026-05-06 | $26.12M derived: sum of 2 quarters · filed 2026-05-06 | $40.64M derived: sum of 3 quarters · filed 2026-05-06 | $52.10M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $14.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $28.86M derived: sum of 2 quarters · filed 2026-03-09 | $40.32M derived: sum of 3 quarters · filed 2026-03-09 | $47.75M 10-K · filed 2026-03-09 | $59.63M 10-K · filed 2025-03-07 | |||
| 2024-09-30 | $14.52M 10-Q · filed 2025-11-10 | $16.77M 10-Q · filed 2024-11-12 | $25.98M derived: sum of 2 quarters · filed 2025-11-10 | $33.40M 10-Q · filed 2025-11-10 | $40.81M 10-Q · filed 2024-11-12 | $47.75M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $11.46M 10-Q · filed 2025-08-05 | $14.05M 10-Q · filed 2024-08-06 | $18.88M 10-Q · filed 2025-08-05 | $24.04M 10-Q · filed 2024-08-06 | $33.23M derived: sum of 3 quarters · filed 2025-08-05 | $47.53M derived: sum of 4 quarters · filed 2025-08-05 | ||
| 2024-03-31 | $7.42M 10-Q · filed 2025-05-13 | $9.99M 10-Q · filed 2024-05-03 | $21.77M derived: sum of 2 quarters · filed 2025-05-13 | $36.07M derived: sum of 3 quarters · filed 2025-05-13 | $48.16M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $14.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $28.65M derived: sum of 2 quarters · filed 2025-03-07 | $40.74M derived: sum of 3 quarters · filed 2025-03-07 | $50.23M 10-K · filed 2025-03-07 | ||||
| 2023-09-30 | $14.30M 10-Q · filed 2024-11-12 | $26.39M derived: sum of 2 quarters · filed 2024-11-12 | $35.88M 10-Q · filed 2024-11-12 | $47.52M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $12.09M 10-Q · filed 2024-08-06 | $21.58M 10-Q · filed 2024-08-06 | $33.22M derived: sum of 3 quarters · filed 2024-08-06 | $49.02M derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | $9.49M 10-Q · filed 2024-05-03 | $21.13M derived: sum of 2 quarters · filed 2024-05-03 | $36.93M derived: sum of 3 quarters · filed 2024-05-03 | $48.03M derived: sum of 4 quarters · filed 2024-05-03 | ||||
| 2022-12-31 | $11.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $27.44M derived: sum of 2 quarters · filed 2024-03-08 | $38.55M derived: sum of 3 quarters · filed 2024-03-08 | $46.85M 10-K · filed 2024-03-08 | ||||
| 2022-09-30 | $15.80M 10-Q · filed 2023-11-07 | $26.90M derived: sum of 2 quarters · filed 2023-11-07 | $35.21M 10-Q · filed 2023-11-07 | $51.05M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $11.11M 10-Q · filed 2023-08-08 | $19.41M 10-Q · filed 2023-08-08 | $35.25M derived: sum of 3 quarters · filed 2023-08-08 | $47.80M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $8.31M 10-Q · filed 2023-05-09 | $24.15M derived: sum of 2 quarters · filed 2023-05-09 | $36.69M derived: sum of 3 quarters · filed 2023-05-09 | $44.97M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $15.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $28.39M derived: sum of 2 quarters · filed 2023-03-15 | $36.66M derived: sum of 3 quarters · filed 2023-03-15 | $42.21M 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | $12.54M 10-Q · filed 2022-11-14 | $20.82M derived: sum of 2 quarters · filed 2022-11-14 | $26.36M 10-Q · filed 2022-11-14 | $32.08M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $8.28M 10-Q · filed 2022-08-09 | $13.82M 10-Q · filed 2022-08-09 | $19.54M derived: sum of 3 quarters · filed 2022-08-09 | $25.59M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $5.54M 10-Q · filed 2022-05-10 | $11.26M derived: sum of 2 quarters · filed 2022-05-10 | $17.31M derived: sum of 3 quarters · filed 2022-05-10 | $28.44M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $5.72M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $11.77M derived: sum of 2 quarters · filed 2022-03-11 | $22.89M derived: sum of 3 quarters · filed 2022-03-11 | $26.89M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $6.05M 10-Q · filed 2021-11-04 | $17.18M derived: sum of 2 quarters · filed 2021-11-04 | $21.18M 10-Q · filed 2021-11-04 | |||||
| 2020-06-30 | $11.13M 10-Q · filed 2021-08-04 | $15.13M 10-Q · filed 2021-08-04 | ||||||
| 2020-03-31 | $4.00M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |